In obese subjects with metabolic syndrome and insulin resistance, a two-month treatment with genistein (50 mg/day) significantly improved insulin sensitivity, and the effect was associated with a modification of the gut microbiota (namely an increase in Akkermansia muciniphila) and an increase in oxidative capacity of fatty acids in the skeletal muscle [78]. The gene discussed is INS; the disease is Insulin resistance.